ParenteralDosed ingredient Cosmetic cross-reference

Thiamine Hydrochloride

CAS 67-03-8

Thiamine Hydrochloride (CAS 67-03-8) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

1

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Thiamine Hydrochloride

CAS Number

67-03-8

UNII

M572600E5P

InChIKey

DPJRMOMPQZCRJU-UHFFFAOYSA-M

ChEMBL ID

CHEMBL1200941

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

dosed ingredientnatural productparenteral

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)

Approved or marketed human pharmaceutical use is represented in the source phase field.

ChEMBL CHEMBL1200941 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	22333.212499999998 nM	8	-

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
thiamine hydrochloride	235355	SU	MTHSPL
THIAMINE HYDROCHLORIDE	235355	SU	MTHSPL
Thiamine Hydrochloride	235355	SU	MTHSPL
thiamine hydrochloride	235355	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Thiamine Hydrochloride used for in pharmaceutical contexts?

Thiamine Hydrochloride (CAS 67-03-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Thiamine Hydrochloride?

Thiamine Hydrochloride has 0 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Abscess limb. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Thiamine Hydrochloride also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Thiamine HCl with EU status "permitted".

What clinical phase is Thiamine Hydrochloride in?

Thiamine Hydrochloride is rendered with ChEMBL max phase 4 (approved).